AK112 and Cadonilimab Combined With Chemotherapy for 1L Treatment of Metastatic Pancreatic Cancer

NCT06646055 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

110

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Pancreatic Ductal Adenocarcinoma

Interventions

DRUG: AK112, Cadonilimab, nab-paclitaxel, gemcitabine
DRUG: AK112, Cadonilimab, nab-paclitaxel, gemcitabine
DRUG: AK112, Cadonilimab, nab-paclitaxel, gemcitabine
DRUG: AK112, nab-paclitaxel, gemcitabine
DRUG: nab-paclitaxel, gemcitabine

Sponsor

Akeso